NCT05697978

Brief Summary

To get the visual outcomes for distance and intermediate and binocular defocus curve in patients with implanted monofocal intraocular lens Clareon (IOL; model SY60CL; Alcon Vision LLC) at 3 months after the surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 15, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 26, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

February 23, 2023

Status Verified

February 1, 2023

Enrollment Period

7 months

First QC Date

January 15, 2023

Last Update Submit

February 21, 2023

Conditions

Keywords

intraocular lensmonofocal lensintermediate visual acuity

Outcome Measures

Primary Outcomes (6)

  • Monocular corrected Distance Visual Acuity (CDVA)

    Monocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.

    3 months

  • Binocular corrected Distance Visual Acuity (CDVA)

    Binocular corrected distance visual acuity (CDVA) is measured at 4 m using an ETDRS (Early Treatment Diabetic Retinopathy Study) illumination cabinet (Precision Vision) under photopic conditions.

    3 months

  • Monocular uncorrected intermediate visual acuity (UIVA)

    Monocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

    3 months

  • Binocular uncorrected intermediate visual acuity (UIVA)

    Binocular intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

    3 months

  • Monocular distance corrected intermediate visual acuity (DCIVA)

    Monocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

    3 months

  • Binocular distance corrected intermediate visual acuity (DCIVA)

    Binocular distance corrected intermediate visual acuity is measured using printed ETDRS charts for distance of 66cm

    3 months

Secondary Outcomes (1)

  • Binocular defocus curve

    3 months

Study Arms (1)

Monofocal lens

OTHER

Eyes of patients with implanted monofocal aspheric lens Clareon (Alcon LLC)

Device: Monofocal intraocular lens Clareon (Alcon LLC)

Interventions

monofocal aspheric lens implanted in eyes of patient during routine cataract surgery

Monofocal lens

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presence of cataract in both eyes
  • no other ocular pathology affecting visual acuity
  • bilateral phacoemulsification cataract surgery was arranged for both eyes
  • corneal astigmatism up to 0,5 cylinder (measured by IOL Master biometry)
  • dioptric power of both selective lens within 1,5 D range in one patient
  • selecting IOL power between 15 D and 28 D power range

You may not qualify if:

  • complicated cataract
  • corneal opacities or irregularities
  • amblyopia
  • anisometropia
  • coexisting ocular pathologies
  • glaucoma
  • history of ocular surgery
  • refusal or unable to maintain follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Eye Center Prague

Prague, Czech Republic, 11000, Czechia

RECRUITING

Faculty hospital Kralovske Vinohrady

Prague, Czech Republic, 11000, Czechia

RECRUITING

Somich Eye Clinic

Karlovy Vary, 36001, Czechia

RECRUITING

Related Publications (3)

  • Lehmann R, Maxwell A, Lubeck DM, Fong R, Walters TR, Fakadej A. Effectiveness and Safety of the Clareon Monofocal Intraocular Lens: Outcomes from a 12-Month Single-Arm Clinical Study in a Large Sample. Clin Ophthalmol. 2021 Apr 20;15:1647-1657. doi: 10.2147/OPTH.S295008. eCollection 2021.

  • Werner L, Thatthamla I, Ong M, Schatz H, Garcia-Gonzalez M, Gros-Otero J, Canones-Zafra R, Teus MA. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019 Oct;45(10):1490-1497. doi: 10.1016/j.jcrs.2019.05.017. Epub 2019 Aug 6.

  • Bala C, Poyales F, Guarro M, Mesa RR, Mearza A, Varma DK, Jasti S, Lemp-Hull J. Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL. J Cataract Refract Surg. 2022 Feb 1;48(2):136-143. doi: 10.1097/j.jcrs.0000000000000712.

Study Officials

  • Andrea Janekova, MD

    Eye Center Prague

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrea Janekova, MD

CONTACT

Pavel Studeny, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
no masking
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: each patient in group received monofocal intraocular lens in both eyes
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 15, 2023

First Posted

January 26, 2023

Study Start

October 1, 2022

Primary Completion

May 1, 2023

Study Completion

August 1, 2023

Last Updated

February 23, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations